Enterin, Inc.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Previously recorded as Enterin Laboratories, Inc. (to 2019)
2
Ending by 2030
Jul 2029
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due May 19, 2027The maintenance fee for Methods and Compositions for Treating and Preventing Viral Infections (US 10,478,444) comes due May 19, 2027. Unpaid by Nov 19, 2027, it lapses early.
- 1 fee due Oct 28, 2027The maintenance fee for Methods of treating Parkinson's disease using aminosterols and compositions comprising the same (US 10,633,413) comes due Oct 28, 2027. Unpaid by Apr 28, 2028, it lapses early.
Recent changes
- 1 term has ended since Aug 16, 2026
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,981,876 | Polymorphic and amorphous salt forms of squalamine dilactate In force · From the USPTO record | In force | From the USPTO record | |
| US 10,478,444 | Methods and Compositions for Treating and Preventing Viral Infections In force · High confidence | In force | High confidence | |
| US 10,196,420 | Methods of Treating and Preventing Gastrointestinal Motility Disorders Using Aminosterols In force · Medium confidence | In force | Medium confidence | |
| US 10,208,079 | Methods of Treating And/Or Preventing Neurodevelopmental Disorders (AUTISM) Using Aminosterols In force · Medium confidence | In force | Medium confidence | |
| US 10,208,080 | Methods of Treating And/Or Preventing Affective Disorders of the Nervous System (DEPRESSION) Using Aminosterols In force · Medium confidence | In force | Medium confidence | |
| US 10,633,413 | Methods of treating Parkinson's disease using aminosterols and compositions comprising the same In force · From the USPTO record | In force | From the USPTO record | |
| US 11,440,936 | Methods and compositions for stimulation of the intestinal enteroendocrine system for treating diseases or conditions related to the same In force · From the USPTO record | In force | From the USPTO record | |
| US 10,975,116 | Methods of treating and preventing gastrointestinal motility disorders using aminosterols In force · From the USPTO record | In force | From the USPTO record | |
| US 10,040,817 | Methods and compositions for stimulation of the intestinal enteroendocrine system for treating diseases or conditions related to the same In force · From the USPTO record | In force | From the USPTO record | |
| US 11,083,735 | Methods for treating sleep disorders, sleep disturbances, and related symptoms using aminosterol compositions In force · From the USPTO record | In force | From the USPTO record |
Also on record, not counted in the 13: 6 lapsed for an unpaid fee. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
2 pending · 2 abandoned · 20 no status recorded